These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10290681)

  • 21. Effect of local competition on the willingness of community pharmacies to supply medication therapy management services.
    Brooks JM; Klepser DG; Urmie JM; Farris KB; Doucette WR
    J Health Hum Serv Adm; 2007; 30(1):4-27. PubMed ID: 17557694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Managing a pharmaceutical carve-out for profitability.
    Capitation Manag Rep; 2001 Dec; 8(12):190-1, 177. PubMed ID: 11802283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. When patients cannot afford their medications.
    Tseng CW
    Am Fam Physician; 2004 Aug; 70(3):605-6, 608. PubMed ID: 15317446
    [No Abstract]   [Full Text] [Related]  

  • 24. H2 receptor antagonist usage in Missouri Medicaid recipients.
    Douglas KC; Dykstra AM; Fitzpatrick W; Lowrey L; Prosser TR; Rush DR; Stelmach WJ
    Mo Med; 1988 Dec; 85(12):779-80. PubMed ID: 2907095
    [No Abstract]   [Full Text] [Related]  

  • 25. PBM industry today: who's managing drug costs?
    Martin SS
    Manag Care; 2001 Dec; 10(12):36-8. PubMed ID: 11795000
    [No Abstract]   [Full Text] [Related]  

  • 26. The price of pharmaceuticals given managed care health insurance membership.
    Brotman BA
    Pharm Pract Manag Q; 2000 Jul; 20(2):16-9. PubMed ID: 11184047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of managed care on prescription drug use.
    Weiner JP; Lyles A; Steinwachs DM; Hall KC
    Health Aff (Millwood); 1991; 10(1):140-54. PubMed ID: 2045046
    [No Abstract]   [Full Text] [Related]  

  • 28. Managed care outlook. What's behind increases in pharmaceutical spending?
    Manag Care; 1998 Feb; 7(2):70. PubMed ID: 10178891
    [No Abstract]   [Full Text] [Related]  

  • 29. Medicare spending on HMOs and stand-alone drug plans: what is it worth to beneficiaries?
    Austin BJ
    Find Brief; 2008 Nov; 11(8):1-3. PubMed ID: 19035029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strategies for developing a successful Medicare part D formulary.
    Stefanacci RG
    Manag Care; 2005 May; 14(5 Suppl):3-10. PubMed ID: 15962831
    [No Abstract]   [Full Text] [Related]  

  • 31. Managing Medicaid drug expenditures.
    Sudovar SG; Rein SD
    J Health Hum Resour Adm; 1978 Nov; 1(2):200-30. PubMed ID: 10308767
    [No Abstract]   [Full Text] [Related]  

  • 32. Getting serious about generics.
    Sipkoff M
    Manag Care; 2003 Jan; 12(1):36-9. PubMed ID: 12575509
    [No Abstract]   [Full Text] [Related]  

  • 33. Cost containment in HMO pharmacies.
    Zuvekas A; Fox PD; Heinen L; Pollard MR
    GHAA J; 1986; 7(2):22-34. PubMed ID: 10301255
    [No Abstract]   [Full Text] [Related]  

  • 34. New concepts in health benefits. Three-tier drug copays.
    Reese S
    Bus Health; 2000 Apr; 18(4):29-30, 32, 35. PubMed ID: 10915290
    [No Abstract]   [Full Text] [Related]  

  • 35. Therapeutic drug use review reduces incidence of drug related illness.
    Morse ML
    Bus Health; 1986; 3(3):58-9. PubMed ID: 10275297
    [No Abstract]   [Full Text] [Related]  

  • 36. The influence of prescription drug insurance on psychotropic and non-psychotropic drug utilization in Canada.
    Sarma S; Basu K; Gupta A
    Soc Sci Med; 2007 Dec; 65(12):2553-65. PubMed ID: 17761377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. By the Numbers. Prescription drugs and supplies.
    Mod Healthc; 2001 Dec; 31(52 Suppl):30. PubMed ID: 11808395
    [No Abstract]   [Full Text] [Related]  

  • 38. Decomposing pharmaceutical cost growth in different types of health plans.
    Chernew ME; Smith DG; Kirking DM; Fendrick AM
    Am J Manag Care; 2001 Jul; 7(7):667-73. PubMed ID: 11464425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utilization effects of prescription drug benefits in an aging population.
    Gianfrancesco FD; Baines AP; Richards D
    Health Care Financ Rev; 1994; 15(3):113. PubMed ID: 10137793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Status report on Medicare Part D enrollment in 2006: analysis of plan-specific market share and coverage.
    Cubanski J; Neuman P
    Health Aff (Millwood); 2007; 26(1):w1-12. PubMed ID: 17118944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.